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Amino acids represent an essential source of nutrients in all the cell culture media. The concentration of each 
individual amino acid in the media has a huge impact on the performance of the cell culture. Traditionally, their 
concentrations in commercially available basal media have been determined in laborious studies using batch 
and fed-batch experiments. Hence, the resulting amino acid composition in the culture media is optimized based 
on the metabolic requirements of a specific cell line in a batch process. These requirements are likely to be 
different when the cell line is changed and the medium is used in perfusion processes. In order to optimize the 
performance of a perfusion culture by means of increasing cell specific productivity, decreasing byproduct 
formation and minimizing the cell specific perfusion rate, we developed a screening procedure for different 
media with distinct amino acid compositions in pseudo-perfused spin tubes. The results obtained from a 
monoclonal antibody expressing CHO-K1 (GS) cell line in these media revealed significant differences in amino 
acid uptake rates, and led to diverse metabolic behaviors. Cell specific productivities varied in a range of 35 % 
and ammonium production was even completely ceased under certain conditions. The lactate production rates 
differed widely and was mostly influenced by the seed cell density. From the results of an initial screening we 
designed a modified medium to target the amino acid consumption to a desired metabolic state with maximized 
antibody productivity and minimized byproduct formation. The performance of the medium was assessed with a 
perfusion culture in an ATF bioreactor system, where the amino acid consumption was precisely controlled to 
the targeted value by the appropriate feeding of amino acids. This strategy can be potentially widely applied 
across various cell lines to define the optimum concentration of amino acids or other components in perfusion 
media. 
 
 
 
 
